Tables
TABLE 1 RESPIRATORY DRUGS: PIPELINE PRODUCTS 20
TABLE 2 PATENT EXPIRATION OF RESPIRATORY DRUGS 28
TABLE 3 RESPIRATORY DRUGS MARKET REVENUE BY APPLICATION' 2017-2024 ($MILLION) 31
TABLE 4 RESPIRATORY DRUGS MARKET REVENUE BY REGIONS' 2017-2024 ($MILLION) 39
TABLE 5 MAJOR RESPIRATORY DRUGS MARKET ($MILLION) 49
TABLE 6 NOVARTIS AG: OFFERINGS 51
TABLE 7 NOVARTIS AG: RECENT DEVELOPMENTS 52
TABLE 8 NOVARTIS AG RESPIRATORY DRUGS PIPELINE MOLECULES 56
TABLE 9 GLAXOSMITHKLINE PLC: OFFERINGS 58
TABLE 10 GLAXOSMITHKLINE PLC: RECENT DEVELOPMENTS 59
TABLE 11 ASTRA ZENCA PLC: OFFERINGS 66
TABLE 12 ASTRA ZENCA PLC: RECENT DEVELOPMENTS 68
TABLE 13 F. HOFFMANN-LA ROCHE LTD.: OFFERINGS 73
TABLE 14 F. HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS 74
TABLE 15 ROCHE: PIPELINE MOLECULES IN RESPIRATORY DRUGS SEGMENT 78
TABLE 16 VERTEX PHARMACEUTICALS INC.: OFFERINGS 80
TABLE 17 VERTEX PHARMACEUTICALS INC.: RECENT DEVELOPMENTS 80
TABLE 18 VERTEX PHARMACEUTICALS: PIPELINE MOLECULES IN RESPIRATORY DRUGS SEGMENT 84
TABLE 19 BOEHRINGER INGELHEIM GMBH: OVERVIEW 86
TABLE 20 TEVA PHARMACEUTICAL INDUSTRIES LTD.: OVERVIEW 88
TABLE 21 GILEAD SCIENCES INC.: OVERVIEW 89
TABLE 22 BAYER AG: OVERVIEW 91
TABLE 23 BAYER AG: RECENT DEVELOPMENTS 91
TABLE 24 PFIZER INC. OVERVIEW 93
TABLE 25 PFIZER INC.: RECENT DEVELOPMENTS 93
TABLE 26 BRISTOL-MYERS SQUIBB CO.: OVERVIEW 95
TABLE 27 BRISTOL-MYERS SQUIBB CO.: KEY DEVELOPMENTS 95
TABLE 28 MERCK & CO.: OVERVIEW 97
TABLE 29 MERCK & CO.: RECENT DEVELOPMENTS 97
TABLE 30 SANOFI: OVERVIEW 99
TABLE 31 SANOFI: RECENT DEVELOPMENTS 99
TABLE 32 MALLINCKRODT PLC: OVERVIEW 100

LIST OF FIGURE

Charts

CHART 1 RESEARCH METHODOLOGY OF GLOBAL RESPIRATORY DRUGS MARKET 13
CHART 2 GLOBAL RESPIRATORY DRUGS MARKET REVENUE' 2017-2024 ($MILLION) 16
CHART 3 SEGMENTATION OF GLOBAL REPIRATORY DRUGS MARKET 23
CHART 4 PORTER 5 FORCES OF RESPIRATORY DRUGS MARKET 24
CHART 5 PEST ANALYSIS OF REPIRATORY DRUGS MARKET 25
CHART 6 MARKET DYNAMICS - DRO ANALYSIS 26
CHART 7 WORLD POPULATION AGED 65 YEARS AND ABOVE' 1960-2060 (%) 27
CHART 8 DRO - IMPACT ANALYSIS OF GLOBAL RESPIRATORY DRUGS MARKET 30
CHART 9 KEY STAKEHOLDERS 31
CHART 10 RESPIRATORY DRUGS MARKET BY APPLICATION SEGMENTATION' 2017 VS 2024 (%) 33
CHART 11 RESPIRATORY DRUGS MARKET REVENUE IN ASTHMA APPLICATION' 2017-2024 ($MILLION) 35
CHART 12 RESPIRATORY DRUGS MARKET REVENUE IN COPD APPLICATION' 2017-2024 ($MILLION) 36
CHART 13 RESPIRATORY DRUGS MARKET REVENUE IN CYSTIC FIBROSIS APPLICATION' 2017-2024 ($MILLION) 37
CHART 14 RESPIRATORY DRUGS MARKET REVENUE IN ALLERGIC RHINITIS APPLICATION' 2017-2024 ($MILLION) 38
CHART 15 RESPIRATORY DRUGS MARKET REVENUE IN OTHERS APPLICATION' 2017-2024 ($MILLION) 39
CHART 16 RESPIRATORY DRUGS MARKET BY REGIONAL SEGMENTATION' 2017 VS 2024 (%) 40
CHART 17 RESPIRATORY DRUGS MARKET REVENUE IN NORTH AMERICA' 2017-2024 ($MILLION) 42
CHART 18 RESPIRATORY DRUG MARKET REVENUE IN THE EUROPE REGION' 2017-2023 ($MILLION) 44
CHART 19 RESPIRATORY DRUGS MARKET REVENUE IN THE APAC REGION' 2017-2024 ($MILLION) 47
CHART 20 RESPIRATORY DRUGS MARKET REVENUE IN REST OF THE WORLD' 2017-2024 ($MILLION) 48
CHART 21 RESPIRATORY PIPELINE DRUGS IN THE MARKET 50
CHART 22 MARKET SHARE OF MAJOR PLAYERS-2017 (%) 52
CHART 23 NOVARTIS AG: OVERVIEW SNAPSHOT 53
CHART 24 NOVARTIS AG: BUSINESS UNITS 58
CHART 25 NOVARTIS AG: GEOGRAPHICAL PRESENCE 58
CHART 26 NOVARTIS AG: SWOT ANALYSIS 59
CHART 27 GLAXOSMITHKLINE PLC: OVERVIEW SNAPSHOT 62
CHART 28 GLAXOSMITHKLINE PLC: BUSINESS UNITS 65
CHART 29 GLAXOSMITHKLINE PLC: GEOGRAPHIC PRESENCE 67
CHART 30 GSK: REVENUE OF RESPIRATORY PORTFOLIO 68
CHART 31 GLAXOSMITHKLINE PLC: SWOT ANALYSIS 68
CHART 32 ASTRA ZENCA PLC: OVERVIEW SNAPSHOT 71
CHART 33 ASTRA ZENCA PLC: BUSINESS UNITS 75
CHART 34 ASTRA ZENCA PLC: GEOGRAPHIC PRESENCE 76
CHART 35 ASTRA ZENCA PLC: SWOT ANALYSIS 77
CHART 36 F. HOFFMANN-LA ROCHE LTD.: OVERVIEW SNAPSHOT 79
CHART 37 F. HOFFMANN.LA ROCHE LTD.: BUSINESS UNITS 82
CHART 38 F. HOFFMANN-LA ROCHE: GEOGRAPHICAL PRESENCE 83
CHART 39 F. HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS 84
CHART 40 VERTEX PHARMACEUTICALS INC.: OVERVIEW SNAPSHOT 88
CHART 41 VERTEX PHARMACEUTICALS INC.: GEOGRAPHICAL PRESENCE 89
CHART 42 VERTEX PHARMACEUTICALS INC.: SWOT ANALYSIS 90